Additionally, A. muciniphila has shown efficacy in modulating the intestinal immune microenvironment and enhancing the efficacy of programmed cell death ligand 1 (PD-L1) therapy in non-small cell lung cancer [40]. This evidence concerns the gene CD274 and non-small cell lung carcinoma.